New sedative may cut oxygen drops during lung scope exams
NCT ID NCT07395596
First seen Feb 09, 2026 · Last updated May 21, 2026 · Updated 14 times
Summary
This study tests if a newer sedative called remimazolam can lower the chance of low oxygen levels (hypoxia) during a painless lung scope procedure in patients at high risk. About 360 adults with serious health conditions will be randomly assigned to receive either remimazolam or the standard sedative propofol. The goal is to see which drug causes fewer breathing and heart problems and leads to faster recovery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY NODULE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shaoxing City First People's Hospital
NOT_YET_RECRUITINGShaoxing, Zhejiang, 310000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The First Affliated Hospital, Zhejiang University School Of Medicine
RECRUITINGHangzhou, Zhejiang, 310000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.